Company / EPS (Diluted)
Protalix BioTherapeutics, Inc. EPS (Diluted) History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$0.09
FY2025
5-year range
-$1.23 / $0.09
FY2021-FY2025
Trend
+129.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) has fluctuated over the past 10 years, ranging from $-6.37 in FY2019 to $0.61 in FY2017.
Based on SEC 10-K filings.
0.09 in FY2025.
Improved from $-0.62 to $0.09 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (diluted) increased 129.0% year-over-year.
- Peak eps (diluted) was recorded in FY2017.
- Lowest eps (diluted) in the period was in FY2019.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.09 | +129.0% |
| FY2024 | -$0.31 | +50.0% |
| FY2023 | -$0.62 | -181.8% |
| FY2022 | -$0.22 | +82.1% |
| FY2021 | -$1.23 | +31.7% |
| FY2020 | -$1.80 | +71.7% |
| FY2019 | -$6.37 | -1144.3% |
| FY2017 | $0.61 | +290.6% |
| FY2016 | -$0.32 | -6.7% |
| FY2015 | -$0.30 | -130.8% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026